Overview

Efficacy and Safety of Pulsed Infusions of Levosimendan in Outpatients With Advanced Heart Failure

Status:
Unknown status
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of a pulsed application of Levosimendan versus placebo on the composite end-point functional capacity and quality of life.
Phase:
Phase 3
Details
Lead Sponsor:
Medical University Innsbruck
Collaborator:
Orion Corporation, Orion Pharma
Treatments:
Simendan